|Age:||18 years or older|
|Keywords:||cancer, breast cancer, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2–) Breast Cancer, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer, ER+/HER2– Breast Cancer|
|Type:||Biological study, Phase 3|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.